Received Mar 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT / LA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
E-mail received in the Contact Center mailbox on 19FEB2025 at 1:07 PM ET forwarded from Merck employee with the subject line " FW: Correspondence from Sanofi 2025SA021994" reporting a AE for VARICELLA ZOSTER VACCINE LIVE VARICELLA VACCINE" (se; Pyrexia; Contraindicated product administered; This spontaneous report was received from a consumer referring to a 55-year-old female patient. Information regarding the patient's concurrent conditions, medical history, or concomitant medications was not provided. On 20-JAN-2025, the patient was vaccinated with varicella zoster vaccine live, manufacturer unknown, administered in the left arm (dose, route of administration, lot number and expiration date was not reported), it was reported as contraindicated product administered. On 21-JAN-2025 the patient developed a knot on her left arm at the injection site (injection site mass) (latency 5 months approximately) following the first dose of Varicella zoster vaccine live. On the same date, body temperature was measured and showed 101.2 (units not provided) (Pyrexia). At the time of the reporting the outcome of the events was unknown. The causal relationship between the events occurred and the suspect vaccine was not reported.
DUPIXENT
Test Date: 20250121; Test Name: Body temperature; Result Unstructured Data: 101.2 units not provided